ascorbic acid 226 MG / beta carotene 14320 UNT / cuprous oxide 0.8 MG / dl-alpha tocopheryl acetate 200 UNT / zinc oxide 34.8 MG [PreserVision]
RxNorm concept 891791, branded drug component (sbdc).
- RxCUI
- 891791
- Term type
- Branded drug component (SBDC)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/891791 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Related concepts
- ascorbic acid 226 MG / beta carotene 14320 UNT / cuprous oxide 0.8 MG / dl-alpha tocopheryl acetate 200 UNT / zinc oxide 34.8 MG Oral Capsule [PreserVision] (SBD, constitutes)
- PreserVision (BN, has ingredient)
- ascorbic acid 226 MG (SCDC, tradename of)
- beta carotene 14320 UNT (SCDC, tradename of)
- cuprous oxide 0.8 MG (SCDC, tradename of)
- dl-alpha tocopheryl acetate 200 UNT (SCDC, tradename of)
- zinc oxide 34.8 MG (SCDC, tradename of)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 891791 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/891791 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 891791. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.